Surgical versus non-surgical treatment of anterior cruciate ligament (ACL) injuries: a randomised prospective clinical trial
ISRCTN | ISRCTN84752559 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN84752559 |
Secondary identifying numbers | N/A |
- Submission date
- 21/10/2005
- Registration date
- 10/01/2006
- Last edited
- 07/01/2025
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Skin and Connective Tissue Diseases
Plain English Summary
Not provided at time of registration
Contact information
Scientific
Clinical Sciences Lund
Department of Orthopedics
Lund University Hospital
Lund
SE-22185
Sweden
Phone | +46 (0)46 171503 |
---|---|
stefan.lohmander@med.lu.se |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
Scientific title | Surgical versus non-surgical treatment of anterior cruciate ligament (ACL) injuries: a randomised prospective clinical trial |
Study acronym | KANON |
Study hypothesis | To compare the short-term (2 years) and long-term (5 years) outcome of surgical and non-surgical treatment of acute ACL disruptions in a physically active population. The primarily effective hypothesis will be evaluated with a disease-specific patient-relevant questionnaire (Knee injury and Osteoarthritis Outcome Score [KOOS]), the number of treatment failures and the return to pre-injury activity level. |
Ethics approval(s) | Not provided at time of registration |
Condition | Anterior cruciate ligament rupture of the knee |
Intervention | Surgery and structured rehabilitation compared with structured rehabilitation only. |
Intervention type | Other |
Primary outcome measure | 1. KOOS and SF-36 patient-administered questionnaire scores, and number of treatment failures at 2 and 5 years 2. Number and grade of joint changes, including bone marrow and meniscus lesions, assessed by radiographs and MRI at 5 years |
Secondary outcome measures | Knee joint laxity, physical activity level, and molecular markers of joint tissue turnover |
Overall study start date | 15/01/2002 |
Overall study end date | 31/12/2005 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 35 Years |
Sex | Both |
Target number of participants | 120 |
Total final enrolment | 121 |
Participant inclusion criteria | 1. Age 18-35 at entry 2. A history of a knee sprain not more than 4 weeks before inclusion 3. An ACL insufficiency as determined by clinical examination (positive Lachman test and positive pivot shift) and a complete ACL tear as visualized on Magnetic Resonance Imaging (MRI) 4. Activity level 5-9 by Tegner classification 5. A plain radiographic examination with normal joint status or with a small avulsed lateral fragment or grade 1 osteophyte or grade 1 joint space narrowing as determined by the Osteoarthritis Research Society International (OARSI) atlas |
Participant exclusion criteria | 1. Pregnancy 2. Earlier major knee injury or knee surgery other than diagnostic arthroscopy on either knee 3. One of the following associated injuries on either knee: 3.1. Grade III medial collateral ligament injury 3.2. An injury to the lateral/posterolateral ligament complex with significantly increased laxity 3.3. Posterior Cruciate Ligament (PCL) injury 3.4. An unstable meniscus tear that requires repair and post-operative treatment interfering with the rehabilitation protocol 3.5. Bi-compartmental extensive meniscus resections 4. A cartilage injury representing a full thickness loss down to bone visualized on MRI 5. Joint space narrowing (JSN) grade 1 combined with osteophytes or JSN grade 2 or greater in the index or contralateral knee as classified by the OARSI atlas 6. A history of deep vein thrombosis (DVT) or a disorder of the coagulative system 7. Refusing to undergo radiological or surgical interventions due to claustrophobia, etc. 8. General disease that affects physical function or systemic medication/abuse of steroids 9. Any other condition or treatment interfering with the completion of the trial, including patients with metal devices or motion disorders etc. that will be unable to complete MRI examination |
Recruitment start date | 15/01/2002 |
Recruitment end date | 31/12/2005 |
Locations
Countries of recruitment
- Sweden
Study participating centre
SE-22185
Sweden
Sponsor information
Industry
PO Box 117
Lund
SE-22100
Sweden
irene.barsegard@med.lu.se | |
Website | http://www.med.lu.se |
https://ror.org/012a77v79 |
Funders
Funder type
Industry
Government organisation / Local government
- Alternative name(s)
- Faculty of Medicine, Lund University
- Location
- Sweden
No information available
Government organisation / For-profit companies (industry)
- Alternative name(s)
- Pfizer Inc., Pfizer Consumer Healthcare, Davis, Charles Pfizer & Company, Warner-Lambert, King Pharmaceuticals, Wyeth Pharmaceuticals, Seagen
- Location
- United States of America
Government organisation / National government
- Alternative name(s)
- Swedish Research Council, VR
- Location
- Sweden
No information available
No information available
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan | Not provided at time of registration |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | qualitative study results | 10/08/2009 | Yes | No | |
Results article | results | 22/07/2010 | Yes | No | |
Results article | results | 24/01/2013 | Yes | No | |
Results article | results | 01/10/2013 | Yes | No | |
Results article | results | 01/07/2014 | Yes | No | |
Results article | results | 01/01/2015 | Yes | No | |
Results article | results | 01/05/2016 | Yes | No | |
Other publications | exploratory analysis | 01/09/2017 | Yes | No | |
Other publications | exploratory analysis | 01/11/2017 | Yes | No | |
Results article | secondary analysis results | 01/05/2020 | 29/10/2019 | Yes | No |
Results article | results | 04/02/2021 | 09/02/2021 | Yes | No |
Results article | results on association between meniscal integrity and early bone surface area changes | 03/03/2021 | 08/03/2021 | Yes | No |
Results article | 5-year follow up results | 09/03/2021 | 10/03/2021 | Yes | No |
Results article | Secondary analysis of participants randomised to rehabilitation and optional delayed ACL reconstruction (ACLR) or early ACLR and rehabilitation | 03/11/2022 | 04/11/2022 | Yes | No |
Results article | Exploratory analysis | 03/01/2025 | 07/01/2025 | Yes | No |
Editorial Notes
07/01/2025: Publication reference added.
04/11/2022: Publication reference added.
10/03/2021: Publication reference added.
08/03/2021: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the referenc
09/02/2021: Publication reference added.
29/10/2019: Publication reference added.
22/05/2017: Publication reference added.
19/05/2017: Publication reference added.
07/03/2016: Publication reference added.